HEADER VIRAL PROTEIN 08-FEB-02 1KZT TITLE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) PEPTIDE IN TITLE 2 DPC MICELLE CONTAINING AQUEOUS SOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: VPR PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 34-51; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT IS SOURCE 4 NATURALLY FOUND IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (NEW YORK-5 SOURCE 5 ISOLATE) (HIV-1). KEYWDS HIV-1, VPR, SOLUTION STRUCTURE, DODECYLPHOSPHOCHOLINE, MICELLES, KEYWDS 2 VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.ENGLER,T.STANGLER,D.WILLBOLD REVDAT 4 13-NOV-24 1KZT 1 REMARK REVDAT 3 23-FEB-22 1KZT 1 REMARK LINK REVDAT 2 24-FEB-09 1KZT 1 VERSN REVDAT 1 28-AUG-02 1KZT 0 JRNL AUTH A.ENGLER,T.STANGLER,D.WILLBOLD JRNL TITL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) JRNL TITL 2 PEPTIDE IN MICELLE CONTAINING AQUEOUS SOLUTION. JRNL REF EUR.J.BIOCHEM. V. 269 3264 2002 JRNL REFN ISSN 0014-2956 JRNL PMID 12084067 JRNL DOI 10.1046/J.1432-1033.2002.03005.X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851, X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER (X-PLOR), BRUNGER (X-PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE CALCULATED USING REMARK 3 FLOATING CHIRALITY. REMARK 4 REMARK 4 1KZT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-02. REMARK 100 THE DEPOSITION ID IS D_1000015516. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : 100MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2MM VPR(34-51); 100MM REMARK 210 DODECYLPHOSPHOCHOLINE D38; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 5.3, NDEE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 97 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ILE A 37 -156.14 -59.73 REMARK 500 3 ILE A 37 -162.90 -58.68 REMARK 500 6 LEU A 39 -50.72 69.11 REMARK 500 6 TYR A 50 98.94 -174.87 REMARK 500 9 LEU A 39 -44.72 72.49 REMARK 500 9 THR A 49 -73.52 -101.72 REMARK 500 11 ILE A 37 -151.09 -60.61 REMARK 500 13 ARG A 36 92.36 171.67 REMARK 500 15 ILE A 37 -131.24 -73.47 REMARK 500 16 ARG A 36 85.22 -162.67 REMARK 500 16 THR A 49 -54.12 71.82 REMARK 500 18 ILE A 37 -139.42 -68.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 36 0.12 SIDE CHAIN REMARK 500 2 ARG A 36 0.13 SIDE CHAIN REMARK 500 3 ARG A 36 0.31 SIDE CHAIN REMARK 500 4 ARG A 36 0.32 SIDE CHAIN REMARK 500 5 ARG A 36 0.10 SIDE CHAIN REMARK 500 6 ARG A 36 0.23 SIDE CHAIN REMARK 500 7 ARG A 36 0.11 SIDE CHAIN REMARK 500 8 ARG A 36 0.31 SIDE CHAIN REMARK 500 9 ARG A 36 0.31 SIDE CHAIN REMARK 500 10 ARG A 36 0.32 SIDE CHAIN REMARK 500 11 ARG A 36 0.30 SIDE CHAIN REMARK 500 12 ARG A 36 0.32 SIDE CHAIN REMARK 500 13 ARG A 36 0.32 SIDE CHAIN REMARK 500 14 ARG A 36 0.31 SIDE CHAIN REMARK 500 15 ARG A 36 0.29 SIDE CHAIN REMARK 500 16 ARG A 36 0.16 SIDE CHAIN REMARK 500 17 ARG A 36 0.27 SIDE CHAIN REMARK 500 18 ARG A 36 0.21 SIDE CHAIN REMARK 500 19 ARG A 36 0.19 SIDE CHAIN REMARK 500 20 ARG A 36 0.31 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 52 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KZS RELATED DB: PDB REMARK 900 1KZS IS THE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34- REMARK 900 51) PEPTIDE IN AQUEOUS TFE SOLUTION. REMARK 900 RELATED ID: 1KZV RELATED DB: PDB REMARK 900 1KZV IS THE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34- REMARK 900 51) PEPTIDE IN CHLOROFORM METHANOL. DBREF 1KZT A 34 51 UNP P12520 VPR_HV1N5 34 51 SEQRES 1 A 20 ACE PHE PRO ARG ILE TRP LEU HIS ASN LEU GLY GLN HIS SEQRES 2 A 20 ILE TYR GLU THR TYR GLY NH2 HET ACE A 33 6 HET NH2 A 52 3 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N HELIX 1 1 ILE A 37 TYR A 50 1 14 LINK C ACE A 33 N PHE A 34 1555 1555 1.30 LINK C GLY A 51 N NH2 A 52 1555 1555 1.31 SITE 1 AC2 1 GLY A 51 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C ACE A 33 13.327 -0.518 6.051 1.00 0.00 C HETATM 2 O ACE A 33 12.629 -1.013 5.188 1.00 0.00 O HETATM 3 CH3 ACE A 33 14.656 0.157 5.707 1.00 0.00 C HETATM 4 H1 ACE A 33 15.365 -0.016 6.503 1.00 0.00 H HETATM 5 H2 ACE A 33 14.501 1.219 5.587 1.00 0.00 H HETATM 6 H3 ACE A 33 15.042 -0.257 4.786 1.00 0.00 H